Wang Li
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 15
- Epigenetics and DNA Methylation 6
- Cancer-related gene regulation 6
- Hepatology 25
- Hepatocellular Carcinoma Treatment and Prognosis 23
- Co-authors
- Peihong Wu (35 shared papers)Qifeng Chen (23 shared papers)Lujun Shen (20 shared papers)Tao Huang (13 shared papers)Ming Zhao (10 shared papers)Xiangshuo Kong (3 shared papers)Boyang Chang (5 shared papers)Lin Huang (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)Medicine (2 papers)Cancer Medicine (2 papers)Annals of Translational Medicine (2 papers)Cancer (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wang Li
106 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 102
- Hepatology 341
- Cancer Research 371
- Otorhinolaryngology 94
- Oncology 385
- Pulmonary and Respiratory Medicine 347
Countries citing papers authored by Wang Li
This map shows the geographic impact of Wang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Li more than expected).
Fields of papers citing papers by Wang Li
This network shows the impact of papers produced by Wang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Li. The network helps show where Wang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 106 | |
| 2 | 2018 | 101 | |
| 3 | 2015 | 97 | |
| 4 | 2011 | 82 | |
| 5 | 2020 | 78 | |
| 6 | 2017 | 68 | |
| 7 | 2013 | 65 | |
| 8 | 2018 | 64 | |
| 9 | 2013 | 59 | |
| 10 | 2011 | 53 | |
| 11 | 2020 | 51 | |
| 12 | 2011 | 45 | |
| 13 | 2012 | 45 | |
| 14 | 2018 | 42 | |
| 15 | 2014 | 40 | |
| 16 | 2016 | 38 | |
| 17 | 2010 | 36 | |
| 18 | 2014 | 36 | |
| 19 | 2013 | 34 | |
| 20 | 2018 | 32 |
About Wang Li
Wang Li is a scholar working on Molecular Biology, Hepatology, Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 109 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (23 papers), RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (11 papers), Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (6 papers), Immune cells in cancer (5 papers), Head and Neck Cancer Studies (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Hepatology (341 citations), Cancer Research (371 citations), Otorhinolaryngology (94 citations), Oncology (385 citations) and Pulmonary and Respiratory Medicine (347 citations). Wang Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Peihong Wu, Qifeng Chen, Lujun Shen, Tao Huang, Ming Zhao, Xiangshuo Kong, Boyang Chang, Lin Huang, Chang-Chuan Pan and Lianying Guo. Their work appears in journals such as Frontiers in Oncology, Medicine, Cancer Medicine, Annals of Translational Medicine and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.